NewsFlash

Thanks to the involvement of over 80 scientists from various fields the MIATA modules have been updated. The new modules, MIATA version 1, are listed under "Current MIATA Modules" and are subject to a second consulting round. Please, get involved shaping the MIATA modules and send your feedback to input@miataproject.org.

PDF Print E-mail
MIATA Core Team 
  • Cedrik M. Britten, Johannes Gutenberg-University, Mainz, Germany
  • Sylvia Janetzki, ZellNet Consulting, Inc., Fort Lee, NJ, USA
  • Christoph Huber, Association for Immunotherapy of Cancer (CIMT), Mainz, Germany
  • Michael Kalos, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
  • Hyam I. Levitsky, Johns Hopkins University School of Medicine, Baltimore, MD, USA
  • Holden T. Maecker, Stanford University Medical Center, Stanford, CA, USA
  • Cornelius J.M. Melief, Leiden University Medical Center, Leiden, The Netherlands
  • Jill O’Donnell-Tormey, Cancer Research Institute, New York, NY, USA
  • Kunle Odunsi, Roswell Park Cancer Center, Buffalo, NY, USA
  • Lloyd J. Old, Ludwig Institute for Cancer Research, MSKCC, New York, NY, USA
  • Bart O. Roep, Leiden University Medical Center, Leiden, The Netherlands
  • Pedro Romero, Ludwig Institute for Cancer Research, University Hospital (CHUV), Lausanne, Switzerland
  • Sjoerd Van Der Burg, Leiden University Medical Center, Leiden, The Netherlands
  • Axel Hoos, Bristol-Myers Squibb, Wallingford, CT, USA
  • Mark M. Davis, HHMI, Stanford University School of Medicine, Stanford, CA, USA

MIATA Panelists

  • James Allison, MSKCC, New York, NY, USA
  • Lisa Butterfield, University of Pittsburgh Cancer Institute, PA, USA
  • Josephine Cox, IAVI, Rockville, MD, USA
  • Guido Ferrari, Duke University, Durham, NC, USA
  • Sacha Gnjatic, LICR, MSKCC, New York, NY, USA
  • Peter Gottlieb, University of Colorado, USA
  • Cecile Gouttefangeas, University of Tübingen, Germany
  • James Gulley, NCI, NIH, Bethesda, MD, USA
  • Simone Joosten, Leiden University, The Netherlands
  • Samir Khleif, NCI, NIH, Bethesda, MD, USA
  • Peter T. Lee, Immunity, Cambridge, MA, USA
  • Kunle Odunsi, Roswell Park, Buffalo, NY, USA
  • Tom H. M. Ottenhoff, Leiden University Medical Center, The Netherlands
  • Christian Ottensmeier, Southampton University Hospitals, UK
  • Graham Pawelec, University of Tübingen, Germany
  • Anne Plant, National Institute of Standards and Technology, Gaithersburg, MD USA
  • Mario Roederer, VRC, NIH, USA
  • Bart Roep, Leiden University Medical Centre, The Netherlands
  • Padmanee Sharma, MD Anderson Cancer Center, Houston, TX, USA
  • Craig Slingluff, University of Virginia, USA
  • Patricia D’Souza, NIAID, NIH, Bethesda, MD, USA
  • Chris Taylor, The European Bioinformatics Institute, UK
  • Sjoerd Van Der Burg, Leiden University, The Netherlands
  • Jeffrey Weber, Moffitt Cancer Center, Tampa FL, USA
  • Jedd Wolchok, MSKCC, New York, NY, USA

Names of contributors participating in the public consultation phase and their affiliation:

 

Alexander Knuth University Hospital Zürich Zürich Switzerland
Anatoli Malyguine SAIC-Frederick, Inc.  NCI-Frederick Frederick, MD USA
Ann Mander Southampton University Hospitals Southampton UK
Anne L. Plant National Institute of Standards and Technology Gaithersburg, MD USA
Arthur A. Vandenbark Oregon Health & Science University Portland, OR USA
Aubrey Watson Alphavax, Inc. RTP, NC USA
Bart Roep Leiden University Medical Centre Leiden  The Netherlands
Cassian Yee Fred Hutchinson Cancer Research Center Seattle USA
Cecile Gouttefangeas University of Tübingen Tübingen Germany
Christian Ottensmeier Southampton University Hospitals Southampton UK
Christine Bain Transgene SA Illkirch Graffenstaden France
Cristina Musselli  Antigenics Lexington, MA USA
Daniel Speiser Ludwig Institute for Cancer Research, Lausanne Branch University Hospital (CHUV)  Lausanne Switzerland
Darien Toledo Santamaría Center of Molecular Immunology Havana Cuba
Dolores Schendel Helmholtz Zentrum München München Germany
Dominic Warrino ViraCor IBT-Laboratories Lenexa, KS USA
Eckhard Kämpgen Unversity of Erlangen Erlangen Germany
Elizabeth Reap Alphavax, Inc. RTP, NC USA
Fiona Powell University of Sussex Brighton UK
Florian Kern  University of Sussex Brighton UK
Francesco M Marincola National Institutes of Health Bethesda, MD USA
Gerold Schuler Unversity of Erlangen Erlangen Germany
Graham Pawelec University of Tübingen Tübingen Germany
Guido Ferrari Duke University Medical Center Tübingen USA
Hans-Georg Rammensee University of Tübingen Tuebingen Germany
Heinz Zwierzina Innsbruck Medical University Innsbruck Austria
Hiroyoshi Nishikawa Mie University Graduate School of Medicine Mie Japan
Hugues JM Nicolay University Hospital of Siena Siena Italy
 Ian Davis LICR Heidelberg, Victoria Australia
James Allison Memorial Sloan-Kettering Cancer Center New York, NY USA
James L. Gulley Center for Cancer Research, National Cancer Institute National Institutes of Health Bethesda, MD USA
Janet Siebert  Cytoanalytics Denver, CO USA
Jedd Wolchok Memorial Sloan-Kettering Cancer Center New York, NY USA
Jeffrey Weber Moffitt Cancer Center Tampa, Fl USA
Jianda Yuan Memorial Sloan-Kettering Cancer Center New York, NY USA
Jim Lane VRC/NIAID NIAID Bethesda, MD USA
Joanne Parker ViraCor IBT-Laboratories Lenexa, KS USA
John Hural Fred Hutchinson Cancer Research Center Seattle, WA USA
Jonathan Cebon LICR Heidelberg, Victoria Australia
Josephine H Cox International AIDS Vaccine Initiative Rockville, MD USA
Julie Nielsen BC Cancer Agency Victoria, BC Canada
Kimberly Shafer-Weaver SAIC-Frederick, Inc.  NCI-Frederick Frederick, MD USA
Kunle Odunsi Roswell Park Cancer Institute Buffalo USA
Laurence Zitvogel Institut Gustave Roussy Villejuif France
Leif Håkansson University Hospital Linkoeping Linkoeping Sweden
Licia Rivoltini Istituto Nazionale Tumori Milano Italy
Marcelo Navarrete Universitätsklinikum Freiburg Freiburg Germany
Maries van den Broek University Hospital Zürich Zürich Switzerland
Marij JP Schoenmaekers-Welters Leiden University Medical Center  Leiden  The Netherlands
Markus Mäurer Karolinska Institute  Stockholm Sweden
Michele Maio University Hospital of Siena Siena Italy
Padmanee Sharma The University of Texas M. D. Anderson Cancer Center Houston USA
Pamela Norberg Alphavax, Inc. Research Triangle Park, NC USA
Patricia D'Souza  NIAID Bethesda, MD USA
Paul V. Lehmann Cellular Technology Ltd. Shaker Heights, OH USA
Per Thor Straten University Hospital Herlev Herlev Denmark
Philip Greenberg University of Washington Seattle USA
Regina Samorski Immatics Tübingen Germany
Ronald Rooke Transgene SA Illkirch Graffenstaden France
Sacha Gnjatic Memorial Sloan-Kettering Cancer Center New York, NY USA
Sebastian Attig Johannes Gutenberg-University Mainz Mainz Germany
Sebastian Kreiter Johannes Gutenberg-University Mainz Mainz Germany
Simone Joosten Leiden University Medical Center Leiden  The Netherlands
Sine Hardrup University Hospital Herlev Herlev Denmark
Sjoerd H. van der Burg Leiden University Medical Center  Leiden  The Netherlands
Sofija Andjelic Regeneron, Inc. Tarrytown, NY USA
Stefanie Groß Unversity of Erlangen Erlangen Germany
Steffen Walter Immatics Tübingen Germany
Tom H. M. Ottenhoff Leiden University Medical Center Leiden  The Netherlands
Ugur Sahin Johannes Gutenberg-University Mainz Mainz Germany
Uri Lopatin Roche Palo Alto, CA USA
Victor Appay Université Pierre et Marie Curie-Paris 6 Paris France
Vincenzo Cerundolo University of Oxford Oxford UK
Weisan Chen LICR Heidelberg, Victoria Australia
Zaima Mazorra Herrera Center of Molecular Immunology Havana Cuba

 

 
miataproject.org, Powered by Joomla! and designed by SiteGround Joomla Templates